RESEARCHER PROFILE
Professor Alice Rumbold (Filmed November 2023)
Perinatal epidemiologist & Co-Theme Leader of
SAHMRI Women and Kids
South Australian Health and Medical Research Institute &
Research Leader, Robinson Research Institute
University of Adelaide
Adelaide, Australia
Professor Alice Rumbold is Theme Leader of SAHMRI Women and Kids, managing a multidisciplinary research team focussed on improving health outcomes for women, babies and families. She also holds an affiliate position as a Research Leader within the Robinson Research Institute at the University of Adelaide.
An epidemiologist and health services researcher, she is internationally renowned for her leadership of large-scale clinical trials, epidemiological studies and systematic review activities to improve perinatal and reproductive health care. She is passionate about improving health outcomes for women and babies, particularly those experiencing vulnerability. Her current research interests include preterm birth, breastfeeding, human milk banking and infertility.
She has held continuous NHMRC funding as a CI since 2007, totalling >$21.2m across 13 grants, including a NHMRC Career Development Fellowship. Her research has generated significant publications in top-ranking journals such as the New England Journal of Medicine, Lancet Global Health, British Journal of Obstetrics and Gynaecology, Human Reproduction and American Journal of Epidemiology, including 11 papers with over 100 citations.
Professor Rumbold’s current research is primarily focused on improving breastfeeding outcomes in preterm babies. She runs several clinical trials that aim to improve breastfeeding outcomes in premature babies, a vulnerable group that is known to have difficulties with establishing breastfeeding. Alice’s research tests new interventions to improve breastfeeding outcomes in these babies, as breast milk is particularly crucial for their development.
Professor Rumbold finds motivation and inspiration from the families participating in her research. These families often participate while knowing that they may not receive direct benefits from the research. She is also driven by the potential to have lifelong impacts on health and opportunities by improving outcomes in the early months of life.
Apart from research, Professor Rumbold loves music. She enjoys listening to it, playing it, and attending live music events. She is a keen cellist and pianist and was previously involved with the Darwin Symphony Orchestra.
-
Nanoparticles & microparticles to combat antimicrobial resistance
Dr Anjana Jayasree is an emerging research leader in biomaterials, tissue engineering and nanotechnology, recognised internationally for her innovative work on antimicrobial nanoparticles and regenerative therapies. A Postdoctoral Research Fellow at The University of Queensland, she operates at the intersection of materials science, drug delivery and cellular biology, developing advanced metallic-based nanotechnologies to improve both human and animal health outcomes. Her expertise spans nanoparticle synthesis, cell–material interactions, and the design of sophisticated in vitro models to investigate soft-tissue integration, osseointegration, angiogenesis and biofilm formation.
-
Identifying and treating autoimmune neurological disorders
Associate Professor Sudarshini Ramanathan is a neurologist and clinician scientist whose work focuses on autoimmune neurological disorders. Her research has helped identify new neurological syndromes due to antibody-mediated demyelination and encephalitis, and improve diagnostic tools and treatment guidelines for patients with autoimmune diseases affecting the brain, spinal cord, muscles and nerves.
-
Identification & characterisation of molecular drivers of therapeutic resistance
Professor Pieter Eichhorn is an internationally experienced cancer biologist and research leader whose career has been defined by high-impact contributions at the interface of functional genomics, translational oncology, and research infrastructure strategy.
He completed his PhD at the University of Newcastle upon Tyne, contributing to the cloning of the gene associated with Cornelia de Lange Syndrome, before undertaking postdoctoral training at the Netherlands Cancer Institute in the laboratory of René Bernards. There, he performed pioneering functional genetic screens that identified key regulators of oncogenesis and therapy resistance, including critical roles for the PI3K signalling pathway in resistance to targeted breast cancer therapies.
